Drug information provided by: Merative, Micromedex®
Motixafortide injection is used in combination with a granulocyte-colony stimulating factor or G-CSF (eg, filgrastim) to mobilize hematopoietic stem cells (HSC) for collection and transplantation in patients with multiple myeloma (MM).
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.